In Minnesota, synthetic biology firm Calyxt, Inc., has completed the first phase of a research collaboration aimed at developing a soybean capable of producing an oil capable of replacing palm oil in commercial applications. The collaboration with an unnamed, leading global food ingredient manufacturer based in Asia leverages Calyxt’s proprietary PlantSpring™ platform for engineering plant […]
In Minnesota, synthetic biology company Calyxt says it is “evaluating potential strategic alternatives to maximize shareholder value,” including financing alternatives, merger, reverse merger, other business combinations, sale of assets, licensing, or other transactions. Calyxt uses its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce high-value, plant-based chemistries for use in customers’ materials and […]
Calyxt leverages their proprietary PlantSpring tech platform, Plant Cell Matrix structures, and BioFactory production system, to produce plant-based chemistries that are scarce in nature, that have unstable supply chains, or that cannot be produced through fermentation, or other similar methodologies. Calyxt’s highlights, milestones, customers, investments, unprecedented time to market, and more…ready for you now at […]
It’s only the second month of 2022, but there are already many people on the move from some of The Digest’s Hot 50 companies and leading biofuels and biotech organizations. From a new Chief Commercial Officer at Topsoe, the shifting of Ron Lamberty’s role from SVP and Market Development Director to Chief Marketing Officer at […]
In Minnesota, plant-based synthetic biotechnology company Calyxt’s pilot BioFactory production system, installed in late December 2021, is now operational at its headquarters site in Minnesota. Calyxt’s proprietary Plant Cell Matrix systems have been placed in the BioFactory, where they will be used for testing at pilot-scale production. The pilot is currently in its testing period, […]
In Minnesota, Calyxt, Inc., a plant-based synthetic biotechnology company, completed a key milestone in its lab-scale BioFactory manufacturing system with results through the Company’s metabolomics analyses indicating over 15,000 chemical signatures, including both known and as-yet-uncharacterized molecules and building block precursors, chemical compounds involved in chemical reactions that produce other compounds. These chemical signatures form […]
In Minnesota, Calyxt, Inc., a plant-based synthetic biotechnology company, announced a new strategic direction to provide sustainably produced plant-based synthetic biology solutions to an expanded group of end markets and diversified base of customers, leveraging its proprietary PlantSpring Technology Platform and BioFactory Production System, which together will enable Calyxt to rapidly prototype and produce complex […]
In Minnesota, Calyxt, Inc. further expanded its hemp breeding platform with the addition of triploid breeding technology to create seedless hemp. Bringing this technology to hemp cultivation comes on the heels of the company announcing the successful transformation of the hemp genome. Together, these advancements demonstrate industry leadership in modernizing the crop. Like seedless watermelon, […]
In Minnesota, Calyxt, Inc., a plant-based technology company, successfully transformed hemp genome, enabling a step-change in innovation approaches in the species. This transformation technology enables future advancements in hemp such as trait delivery, gene editing and advanced plant breeding and is expected to accelerate hemp variety development. Out of reach by U.S. farmers and seed […]
In Minnesota, Calyxt, Inc., a plant-based technology company, contracted to sell all 2020 grain production of its high oleic soybean to ADM. The total purchases represent approximately four million bushels of high oleic soybean grain. ADM is responsible to crush the grain and will market and sell the resulting oil and meal. Calyxt’s high oleic […]
